We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...

Sandoz Inc.'s proposed copies of Crexont infringe 12 patents for the Parkinson’s disease treatment, two Amneal Pharmaceuticals Inc. units said in the first federal infringement lawsuit over the drug ...

After hours: January 13 at 4:46:38 PM EST Loading Chart for AMRX ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) develops and distributes affordable generic and specialty drugs, including key diabetes treatments. Its products include generic metformin, a first-line ...

The subsidiary seeks damages and injunctions. Vandana Singh Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts Amneal Pharmaceuticals Q3 sales rose 13% to $702.47 ...

In this article, we are going to take a look at where Amneal Pharmaceuticals ... Rising Demand for GLP-1 Medications: Opportunities and Challenges in Diabetes and Obesity Treatment The management ...

"And to claim that drug, the patent must claim at least the active ingredient." The case is Teva Branded Pharmaceutical Products R&D Inc v. Amneal Pharmaceuticals of New York LLC, U.S. Court of ...